1. Home
  2. CTW vs SCLX Comparison

CTW vs SCLX Comparison

Compare CTW & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTW
  • SCLX
  • Stock Information
  • Founded
  • CTW 2013
  • SCLX 2011
  • Country
  • CTW Japan
  • SCLX United States
  • Employees
  • CTW N/A
  • SCLX N/A
  • Industry
  • CTW EDP Services
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTW Technology
  • SCLX Health Care
  • Exchange
  • CTW Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • CTW 131.0M
  • SCLX 139.3M
  • IPO Year
  • CTW 2025
  • SCLX N/A
  • Fundamental
  • Price
  • CTW $2.35
  • SCLX $15.30
  • Analyst Decision
  • CTW
  • SCLX Hold
  • Analyst Count
  • CTW 0
  • SCLX 1
  • Target Price
  • CTW N/A
  • SCLX N/A
  • AVG Volume (30 Days)
  • CTW 285.0K
  • SCLX 140.1K
  • Earning Date
  • CTW 11-17-2025
  • SCLX 08-13-2025
  • Dividend Yield
  • CTW N/A
  • SCLX N/A
  • EPS Growth
  • CTW N/A
  • SCLX N/A
  • EPS
  • CTW N/A
  • SCLX N/A
  • Revenue
  • CTW $76,194,020.00
  • SCLX $40,360,000.00
  • Revenue This Year
  • CTW N/A
  • SCLX $89.26
  • Revenue Next Year
  • CTW N/A
  • SCLX $203.95
  • P/E Ratio
  • CTW $51.43
  • SCLX N/A
  • Revenue Growth
  • CTW 8.71
  • SCLX N/A
  • 52 Week Low
  • CTW $1.71
  • SCLX $3.60
  • 52 Week High
  • CTW $4.88
  • SCLX $34.27
  • Technical
  • Relative Strength Index (RSI)
  • CTW N/A
  • SCLX 42.42
  • Support Level
  • CTW N/A
  • SCLX $17.28
  • Resistance Level
  • CTW N/A
  • SCLX $19.56
  • Average True Range (ATR)
  • CTW 0.00
  • SCLX 1.97
  • MACD
  • CTW 0.00
  • SCLX -0.02
  • Stochastic Oscillator
  • CTW 0.00
  • SCLX 3.68

About CTW CTW Cayman Class A Ordinary Shares

CTW Cayman is a web-based gaming platform, offering players an immersive digital space through flagship HTML5 platform, G123.jp. The company's primary focus is to serve game developers by providing a comprehensive platform that helps them generate revenue and reach a global audience. The platform offers a diverse selection of free-to-play games inspired by popular Japanese animations and it hosts 28 games, with 9 additional titles in pre-registration.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: